Group 5E: Metastatic Breast Cancer; Brain Metastases; Her2-low; Genomics

Poster #P3-08-21: Trastuzumab-deruxtecan in HER2-low metastatic breast cancer patients with newly diagnosed or progressing brain metastases: The TUXEDO-4 phase II trial

Poster #P5-06-10: Clinical and Transcriptomic Study of Matched Primary Breast Cancer and Brain Metastasis